Dashboard
Poor long term growth as Operating profit has grown by an annual rate -5.46% of over the last 5 years
- PAT(Q) At Rs 28.37 cr has Fallen at -57.8% (vs previous 4Q average)
- NET SALES(Q) At Rs 473.03 cr has Fallen at -10.7% (vs previous 4Q average)
- DEBTORS TURNOVER RATIO(HY) Lowest at 1.26 times
With ROE of 9.3, it has a Expensive valuation with a 2.7 Price to Book Value
Below par performance in long term as well as near term
Stock DNA
Pharmaceuticals & Biotechnology
INR 6,668 Cr (Small Cap)
30.00
34
0.00%
-0.17
9.27%
2.75
Total Returns (Price + Dividend) 
Latest dividend: 5 per share ex-dividend date: Nov-22-2024
Risk Adjusted Returns v/s 
Returns Beta
News

FDC Sees Revision in Market Assessment Amidst Challenging Financial Trends
FDC, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market assessment reflecting recent shifts in its financial and technical outlook. The changes stem from a combination of valuation concerns, subdued financial performance, and technical indicators that suggest caution for investors.
Read More
FDC Sees Revision in Market Assessment Amidst Challenging Financial Trends
FDC, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable revision in its market evaluation, reflecting shifts in its financial and technical outlook. This adjustment comes amid a backdrop of subdued operational performance and valuation concerns, prompting investors to reassess the stock’s position within its sector.
Read MoreIs FDC technically bullish or bearish?
As of 18 November 2025, the technical trend has changed from mildly bearish to bearish. The current technical stance for FDC is bearish with a moderate strength. Key indicators driving this stance include a bearish MACD on the weekly timeframe, bearish moving averages on the daily timeframe, and a bearish signal from Bollinger Bands on both weekly and monthly timeframes. The KST is also bearish on the weekly, reinforcing the negative outlook. Although the OBV shows a bullish signal on the monthly, it does not outweigh the overall bearish indicators....
Read More Announcements 
Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
24-Dec-2025 | Source : BSEIntimation of Postal Ballot notice
Closure of Trading Window
24-Dec-2025 | Source : BSEIntimation of Closure of Trading Window
Announcement under Regulation 30 (LODR)-Change in Registered Office Address
19-Dec-2025 | Source : BSEChange in Registered Office Address
Corporate Actions 
No Upcoming Board Meetings
FDC Ltd has declared 500% dividend, ex-date: 22 Nov 24
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Sep 2025
Shareholding Compare (%holding) 
Promoters
None
Held by 9 Schemes (6.63%)
Held by 100 FIIs (2.43%)
Nomita R Chandavarkar (22.67%)
Icici Prudential Smallcap Fund (3.59%)
16.4%
Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ
QoQ Growth in quarter ended Sep 2025 is -27.05% vs 31.82% in Jun 2025
QoQ Growth in quarter ended Sep 2025 is -76.62% vs 213.81% in Jun 2025
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is -2.66% vs 12.65% in Sep 2024
Growth in half year ended Sep 2025 is -21.65% vs 6.33% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'24
YoY Growth in nine months ended Dec 2024 is 9.14% vs 9.78% in Dec 2023
YoY Growth in nine months ended Dec 2024 is -11.90% vs 58.54% in Dec 2023
Annual Results Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is 8.50% vs 8.92% in Mar 2024
YoY Growth in year ended Mar 2025 is -12.59% vs 57.30% in Mar 2024






